DepYmed

Farmingdale, NY · Founded 2014 · Privately Held (backing)

Developer of potent inhibitors of the enzyme designed to offer therapeutics for cancer and rare diseases. DepYmed is based in Farmingdale, NY and was founded in 2014. Its last reported valuation was $36.3 million in Apr 2021. It has raised $14.3 million across 6 recorded rounds; the latest was a $250,000 seed round in Apr 2025.

Last reported valuation
$36.3M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Apr 2025

Who backs DepYmed?

8 investors
InvestorType
Accelerate Long Island—
Cold Spring Harbor Laboratory—
Jove Equity Partners—
Long Island Emerging Technologies Fund—
Long Island Emerging Technologies Fund (LIETF)—
NeuBase Therapeutics—
Ohr Pharmaceutical—
Topspin Consumer Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

DepYmed investors

8 investors are on record for DepYmed, including Accelerate Long Island, Cold Spring Harbor Laboratory, Jove Equity Partners and Long Island Emerging Technologies Fund. The seed round in Apr 2025 drew 1 investor.

Free account
More of DepYmed with a free account
  • ·Watch DepYmed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like DepYmed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View